Solid-Phase Polyamine Synthesis Using Piperazine and Piperidine Building Blocks

Organic Letters

Volumn 5, Issue 22, 2003, Pages 4183-4185

  Olsen, Christian A ^a   Witt, Matthias ^b   Jaroszewski, Jerzy W ^a   Franzyk, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BRUKER DALTONIK GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHILANTHOTOXIN; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; POLYAMINE DERIVATIVE;

ALKYLATION; ARTICLE; DRUG SYNTHESIS; METHODOLOGY; SOLID;

EID: 0344944897     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol035610t     Document Type: Article

References (36)

1. (a) Eldefrawi, A. T.; Eldefrawi, M. E.; Konno, K.; Mansour, N. A.; Nakanishi, K.; Eugene, O.; Usherwood, P. N. R. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4910-4913.
2. (b) Karigiannis, G.; Papaioannou, D. Eur. J. Org. Chem. 2000, 1841-1863.
3. (a) Strømgaard, K.; Andersen, K.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. Mini Rev. Med. Chem. 2001, 1, 317-338.
4. (b) Usherwood, P. N. R. Il Farmaco 2000, 55, 202-205.
5. (c) Nakanishi, K.; Goodnow, R.; Konno, K.; Niwa, M.; Bukownik, R.; Kallimopoulos, T.; Usherwood, P. N. R.; Eldefrawi, A. T.; Eldefrawi, M. E. Pure Appl. Chem. 1990, 62, 1223-1230.
6. (a) Mueller, A. L.; Roeloffs, R.; Jackson, H. In The Alkaloids, Cordell, G. A., Ed.; Academic Press: New York, 1995; Vol. 46, pp 63-94.
7. (b) Green, A. C.; Nakanishi, K.; Usherwood, P. N. R. Brain Res. 1996, 717, 135-146.
8. (c) Blagbrough, I. S.; Carrington, S.; Geall, A. J. Pharm. Sci. 1997, 3, 223-233.
9. Wang, F.; Manku, S.; Hall, D. G. Org. Lett. 2000, 2, 1581-1583.
10. Chhabra, S. R.; Khan, A. N.; Bycroft, B. W. Tetrahedron Lett. 2000, 41, 1095-1098.
11. (a) Hone, N. D.; Payne, L. J. Tetrahedron Lett. 2000, 41, 6149-6152.
12. (b) Strømgaard, K.; Andersen, K.; Ruhland, T.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. Synthesis 2001, 877-884.
13. (a) Kan, T.; Kobayashi, H.; Fukuyama, T. Synlett 2002, 1338-1340.
14. (b) Tomasi, S.; Le Roch, M.; Renault, J.; Corbel, J. C.; Uriac, P. Pharm. Pharmacol. Commun. 2000, 6, 155-159.
15. (a) TenBrink, R. E.; McCall, J. M.; Johnson, H. G. J. Med. Chem. 1980, 23, 1058-1060.
16. (b) Sjö, P.; Aasen, A. J. Acta Chem. Scand. 1993, 47, 486-491.
17. (c) Isono, N.; Mori, M. J. Org. Chem. 1995, 60, 115-119.
18. (d) Doller, D.; Chackalamannil, S.; Czarniecki, M.; McQuade, R.; Ruperto, V. Bioorg. Med. Chem. Lett. 1999, 9, 901-906.
19. (e) Tietze, L. F.; Schirok, H.; Wöhrmann, M.; Schrader, K. Eur. J. Org. Chem. 2000, 2433-2444.
20. (a) Virgilio, A. A.; Schürer, S. C.; Ellman, J. A. Tetrahedron Lett. 1996, 37, 6961-6964.
21. (b) Lee, C. E.; Kick, E. K.; Ellman, J. A. J. Am. Chem. Soc. 1998, 120, 9735-9747.
22. (c) Renault, J.; Lebranchu, M.; Lecat, A.; Uriac, P. Tetrahedron Lett. 2001, 42, 6655-6658.
23. (a) Bruce, M.; Bukownik, R.; Eldefrawi, A. T.; Eldefrawi, M. E.; Goodnow, R.; Kallimopoulos, T.; Konno, K.; Nakanishi, K.; Niwa, M.; Usherwood, P. N. R. Toxicon 1990, 28, 1333-1346.
24. (b) Olsen, C. A.; Jørgensen, M. R.; Witt, M.; Mellor, I. R.; Usherwood, P. N. R.; Jaroszewski, J. W.; Franzyk, H. Eur. J. Org. Chem. 2003, 3288-3299.
25. (a) Strømgaard, K.; Brierley, M. J.; Andersen, K.; Sloøk, F. A.; Mellor, I. R.; Usherwood, P. N. R.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. J. Med. Chem. 1999, 42, 5224-5234.
26. (b) Mellor, I. R.; Brier, T. J.; Pluteanu, F.; Strømgaard, K.; Saghyan, A.; Eldursi, N.; Brierley, M. J.; Andersen, K.; Jaroszewski, J. W.; Krogsgaard-Larsen, P.; Usherwood, P. N. R. Neuropharmacology 2002, 44, 70-80.
27. Jaroszewski, J. W.; Matzen, L.; Frølund, B.; Krogsgaard-Larsen, P. J. Med. Chem. 1996, 39, 515-521.
28. 2), and 73% (THF/PhMe).
29. 1-mononosylpiperazine (18%), while no sulfonamide formation was observed in solution-phase reactions.
30. (a) Carpino, L. A.; Tsao, J.-H. J. Chem. Soc., Chem. Commun. 1978, 358-359.
31. (b) Koh, J. S.; Ellman, J. A. J. Org. Chem. 1996, 61, 4494-4495.
32. (a) Carpino, L. A.; Han, G. Y. J. Org. Chem. 1972, 37, 3404-3409.
33. (b) Green, M.; Judd, B. Tetrahedron Lett. 1990, 31, 5851-5852.
34. (c) Wellendorph, P.; Jaroszewski, J. W.; Hansen, S. H.; Franzyk, H. Eur. J. Med. Chem. 2003, 38, 117-122.
35. Zaragoza, F.; Stephensen, H. J. Org. Chem. 2001, 66, 2518-2521.
36. Salvino, J. M.; Gerard, B.; Ye, H. F.; Sauvagnat, B.; Dolle, R. E. J. Comb. Chem. 2003, 5, 260-266.